| HIF Inhibitors: Status of Current Clinical Development |
40 |
| CDK 4/6 Inhibitors in Breast Cancer: Current Controversies and Future Directions |
23 |
| The World of Melanoma: Epidemiologic, Genetic, and Anatomic Differences of Melanoma Across the Globe |
23 |
| Mucosal Melanoma: a Literature Review |
21 |
| Molecular Subtypes of Bladder Cancer |
20 |
| Emerging Targeted Therapies for the Treatment of Non-small Cell Lung Cancer |
20 |
| Triple-Negative Breast Cancers: Systematic Review of the Literature on Molecular and Clinical Features with a Focus on Treatment with Innovative Drugs |
19 |
| Immune Checkpoint Inhibitor Toxicity |
17 |
| Primary Osteosarcoma in the Elderly Revisited: Current Concepts in Diagnosis and Treatment |
17 |
| Recent Development of Wnt Signaling Pathway Inhibitors for Cancer Therapeutics |
17 |
| Updates on Management of Gastric Cancer |
15 |
| The Impact of Obesity on Breast Cancer Diagnosis and Treatment |
15 |
| Immunotherapy for Head and Neck Squamous Cell Carcinoma |
15 |
| Qigong or Tai Chi in Cancer Care: an Updated Systematic Review and Meta-analysis |
14 |
| Molecular Subtypes of Prostate Cancer |
14 |
| The Present and Future of Liquid Biopsies in Non-Small Cell Lung Cancer: Combining Four Biosources for Diagnosis, Prognosis, Prediction, and Disease Monitoring |
14 |
| The Impact of Obesity on Breast Cancer |
14 |
| New Treatment Options for Acute Myeloid Leukemia in 2019 |
14 |
| Immune Checkpoint Inhibitors in Acute Myeloid Leukemia: Novel Combinations and Therapeutic Targets |
13 |
| Colon Cancer in Young Adults: Trends and Their Implications |
13 |
| Poor-Performance Status Assessment of Patients with Non-small Cell Lung Cancer Remains Vague and Blurred in the Immunotherapy Era |
12 |
| Indoleamine Dioxygenase Inhibitors: Clinical Rationale and Current Development |
12 |
| Plasma Cell Leukemia: Definition, Presentation, and Treatment |
12 |
| Pharmacogenetics of Chemotherapy-Induced Cardiotoxicity |
11 |
| Molecular Mechanisms of Cisplatin Chemoresistance and Its Circumventing in Testicular Germ Cell Tumors |
11 |
| Modifiable Host Factors in Melanoma: Emerging Evidence for Obesity, Diet, Exercise, and the Microbiome |
11 |
| The Role of Oncolytic Viruses in the Treatment of Melanoma |
10 |
| Melanoma and Immune Checkpoint Inhibitors |
10 |
| Combination Immune Checkpoint Blockade Strategies to Maximize Immune Response in Gynecological Cancers |
10 |
| Systemic Histiocytosis (Langerhans Cell Histiocytosis, Erdheim-Chester Disease, Destombes-Rosai-Dorfman Disease): from Oncogenic Mutations to Inflammatory Disorders |
10 |
| What Is the Role of Imaging at Primary Diagnostic Work-Up in Uterine Cervical Cancer? |
9 |
| Changes in the 8th Edition of the American Joint Committee on Cancer (AJCC) Staging of Head and Neck Cancer: Rationale and Implications |
9 |
| Flaxseed Bioactive Compounds and Colorectal Cancer Prevention |
9 |
| Long-term Effects of Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation in Pediatric Patients with Acute Lymphoblastic Leukemia |
9 |
| Immunotherapy in Prostate Cancer: Teaching an Old Dog New Tricks |
9 |
| Management of Adrenocortical Carcinoma |
9 |
| Prevention Strategies in Endometrial Carcinoma |
9 |
| PI3K Inhibitors in Breast Cancer Therapy |
8 |
| Current Status of Immunotherapies for Treating Pancreatic Cancer |
8 |
| Updates in the Diagnosis and Treatment of Paraneoplastic Neurologic Syndromes |
8 |
| Olfactory Neuroblastoma |
8 |
| BET and EZH2 Inhibitors: Novel Approaches for Targeting Cancer |
8 |
| Physical Activity and Breast Cancer: an Opportunity to Improve Outcomes |
8 |
| Molecular Pathways in Melanomagenesis: What We Learned from Next-Generation Sequencing Approaches |
8 |
| Targeting DNA Repair Defects for Precision Medicine in Prostate Cancer |
8 |
| Combination Immunotherapy in Non-small Cell Lung Cancer |
7 |
| Cerebral Radiation Necrosis: Incidence, Pathogenesis, Diagnostic Challenges, and Future Opportunities |
7 |
| Surgical Management of Lung Cancer: History, Evolution, and Modern Advances |
7 |
| The Utility of Liquid Biopsy in Central Nervous System Malignancies |
7 |
| Cytokine Release Syndrome With the Novel Treatments of Acute Lymphoblastic Leukemia: Pathophysiology, Prevention, and Treatment |
7 |
